CS192484B2 - Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins - Google Patents

Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins

Info

Publication number
CS192484B2
CS192484B2 CS773624A CS362477A CS192484B2 CS 192484 B2 CS192484 B2 CS 192484B2 CS 773624 A CS773624 A CS 773624A CS 362477 A CS362477 A CS 362477A CS 192484 B2 CS192484 B2 CS 192484B2
Authority
CS
Czechoslovakia
Prior art keywords
dehydroprostaglandins
omega
racemic
aromatic
optically active
Prior art date
Application number
CS773624A
Other languages
Czech (cs)
English (en)
Inventor
Carmelo Gandolfi
Franco Faustini
Walter Moretti
Maria M Usardi
Roberto Ceserani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of CS192484B2 publication Critical patent/CS192484B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
CS773624A 1976-06-01 1977-06-01 Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins CS192484B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (1)

Publication Number Publication Date
CS192484B2 true CS192484B2 (en) 1979-08-31

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
CS773624A CS192484B2 (en) 1976-06-01 1977-06-01 Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins

Country Status (18)

Country Link
US (1) US4195183A (fr)
JP (1) JPS52148044A (fr)
AT (2) AT356302B (fr)
AU (1) AU509127B2 (fr)
BE (1) BE855236A (fr)
CA (1) CA1115700A (fr)
CH (1) CH634831A5 (fr)
CS (1) CS192484B2 (fr)
DE (1) DE2721534A1 (fr)
DK (1) DK233377A (fr)
FR (1) FR2368473A1 (fr)
GB (1) GB1583263A (fr)
HU (1) HU181424B (fr)
IL (1) IL51877A (fr)
NL (1) NL7705701A (fr)
NZ (1) NZ184187A (fr)
SE (1) SE436026B (fr)
SU (1) SU932985A3 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP2005519115A (ja) * 2002-03-01 2005-06-30 アラーガン、インコーポレイテッド プロスタミドの製造
WO2010102078A1 (fr) 2009-03-04 2010-09-10 Allergan, Inc. Solution ophtalmique améliorée à base de bimatoprost
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
AU2009354014B2 (en) * 2009-10-16 2014-08-28 Cayman Chemical Company, Incorporated Process for the preparation of F-series prostaglandins
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA765031B (en) * 1975-09-10 1977-10-26 Univ Chicago Fluorinated prostaglandins and related compounds and chemical process

Also Published As

Publication number Publication date
NL7705701A (nl) 1977-12-05
US4195183A (en) 1980-03-25
AT367747B (de) 1982-07-26
GB1583263A (en) 1981-01-21
JPS52148044A (en) 1977-12-08
SU932985A3 (ru) 1982-05-30
JPS6140662B2 (fr) 1986-09-10
DK233377A (da) 1977-12-02
AT356302B (de) 1980-04-25
AU509127B2 (en) 1980-04-24
ATA333477A (de) 1979-09-15
FR2368473B1 (fr) 1981-09-11
IL51877A0 (en) 1977-06-30
SE7706310L (sv) 1977-12-02
DE2721534A1 (de) 1977-12-15
FR2368473A1 (fr) 1978-05-19
IL51877A (en) 1981-09-13
AU2465677A (en) 1978-11-02
CA1115700A (fr) 1982-01-05
NZ184187A (en) 1978-07-28
BE855236A (fr) 1977-11-30
ATA383179A (de) 1981-12-15
SE436026B (sv) 1984-11-05
HU181424B (en) 1983-07-28
CH634831A5 (en) 1983-02-28

Similar Documents

Publication Publication Date Title
PH19006A (en) Process for the preparation of new optically active 1,4-dihydropyridine
YU217477A (en) Process for obtaining optically active substituted azabicyclohexanes
CS192484B2 (en) Method of preparing optically active or racemic omega-nor-aromatic 13,14-dehydroprostaglandins
BG31226A4 (en) Method for obtaining of racemic oropticallj active pjromido (1,2a) heterocjlic commpounds
GB1546015A (en) Racemization of optically active compound
IT1165334B (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree
BG28987A4 (en) Method of obtaining of n- (1,3,4- thiadizol- 2- il)- benzamid
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG28054A3 (en) Method of obtaining of 2-(4-aroylpiperazine-1-il)-4- amino-6,7-dimetoxyhinazoline
SU725557A3 (en) Method of preparing 1,2,3-thiadiazol-5-yl-ureas
CS189001B2 (en) Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines
DE2860470D1 (en) Method of preparing 2,2'-dithiodianiline
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
IL51574A (en) Process for preparing racemic and optically active 1-tert-butylamino-3-(2,5-dichloro-phenoxy)-2propanol
CS191296B2 (en) Process for preparing optically active or racemic fluorprostaglandine
IL52643A0 (en) Method of preparing 2,3-dichloroanisole
SU701538A3 (ru) Способ получени солей 2-диметилкарбамоилимино-1,3,4-тиадиазолин-3-ида
SU574431A1 (ru) Способ получени 1,3-диолов
BG27914A4 (en) Method of obtaining of 8,8 a-dexy-8,8-a- cyclopropiloleandomyzin
PT66747A (en) Process for preparing of optically active trans-hexahydro-dibenzopyranones
SE438506B (sv) Forfarande for framstellning av 5,6-dehydropenicilliner
CS222191B2 (en) Method of making the optically active or racemic derivatives of the 7-oxo-pgi 2
CS182579B1 (en) Method of preparing 2,2'-dibenzothiazyldisulphide
PH12245A (en) Method for the cultivation of basidionycetes